Power Law company profile

Gelesis

Biotech & Life Sciences · Boston, United States · Founded 2006 Unicorn

Biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients

Valuation

$54M

Market cap · May/2026

Revenue

$26M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

7 investors on Gelesis's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage

Cormorant Asset Management

Invesco

QIC BioVentures

PureTech

OrbiMed

Salica Investments

Vitruvian Partners

Global footprint

Where Gelesis has talent and traffic

Workforce by country

4 countries with
team presence

🇮🇹 Italy88.2%

🇺🇸 United States5.9%

🇮🇱 Israel3%

🇬🇧 United Kingdom3%

4 countries shown

Web traffic by country

310 monthly visits
across markets

🇺🇸 United States64.5%

🇮🇹 Italy32.3%

Top 2 markets shown

Patent intelligence

$45M patent portfolio · 18 active families

Estimated portfolio value

$45M

83.8% of market cap · comparable to top peer Cathay Industrial Biotech ($54M)

18 active patent families

Where Gelesis innovates Polymer sciencePolymerCarboxymethyl celluloseCelluloseMethyl cellulose

Where Gelesis concentrates vs peers

Each axis is a top-10 topic across Gelesis and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Gelesis

An AI-synthesized read of the highest-engagement posts about Gelesis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Gelesis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles